Johnson & Johnson (SNSE:JNJ)

Chile flag Chile · Delayed Price · Currency is CLP · Price in USD
191.05
0.00 (0.00%)
At close: Dec 5, 2025
28.85%
Market Cap 449.01T
Revenue (ttm) 88.44T
Net Income (ttm) 24.11T
Shares Out n/a
EPS (ttm) 9,930.89
PE Ratio 18.63
Forward PE 18.00
Dividend 4,865.72 (2,546.83%)
Ex-Dividend Date Nov 25, 2025
Volume n/a
Average Volume n/a
Open n/a
Previous Close 191.05
Day's Range n/a
52-Week Range 143.62 - 191.05
Beta 0.66
RSI 100.00
Earnings Date Jan 21, 2026

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo... [Read more]

Industry Drug Manufacturers - General
Sector Healthcare
Founded 1886
Employees 138,100
Stock Exchange Santiago Stock Exchange
Ticker Symbol JNJ
Full Company Profile

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD Financial Statements

News

There is no news available yet.